A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine

Recruiting

Phase 2

MVA-BN-WEVA Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine

Sponsor:

Bavarian Nordic

Code:

NCT06899802

Conditions

Encephalitis

Eligibility Criteria

Sex: All

Age: 18 - 50

Healthy Volunteers: Accepted

Interventions

MVA-BN-WEV

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Bavarian Nordic on 2025-03-28.